GHISLAINE MAXWELL ACCT. For the Period 10/1/13 to 10/31/13 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity 969,621.57 986,618.54 16.996 97 50,794.36 21% Alternative Assets 63,386.38 63.084.56 (301 83) 1% Cash 8 Fixed Income 3,980,583.81 4,001,238.07 20.654 26 21,388.24 75% Other 158,652.35 158.95851 306.16 3% Market Value Accruals $6,172,244.11 $6,209,899.67 S37,656.66 14121.73 8229.05 (5 892 68) $72,182.80 100% Market Value with Accruals $6,186,366.84 $6,218,128.72 831,762.88 Portfolio Activity Current Year-to•Date Period Value Value Beginning Market Value 6,172,244.11 8,349,268.16 Contributions Withdrawals 8 Fees Secunties Transferred In 849,480.50 (248.53) (4.002.239.16) 1,607,746.17 13,360,849.93 Securities Transferred Out 1 607 497.61 (14.239.914.96) Net Contributions/Withdrawals Income tt Distributions $0.03 ($4,031,823.69) 17,145.01 (14,224.35) Change In Investment Value 20.510.52 936.689 55 Ending Market Value Accruals $6,208,898.67 $6.209,899.67 8,229.05 8 229 05 Market Value with Accruals 66,218,128.72 $5.218.128.72 JP Morgan Other Alleimrive AsserS Equay _Cash Fixed roomy Page 2 of 31 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049265 SDNY_GM_00318463 EFTA01521830